2m 2m 2m 2m 2m 2m 2m
RELAY THERAPETCS (RLAY)
NASDAQ
$19.75+$0.31 (+1.59%)
Price as of Aug 21, 2026 7:57 PM EDT- $4.3BMarket Cap
- 426.83%1-Year Change
- BiotechnologyIndustry
RELAY THERAPETCS (RLAY)
$19.75+$0.31 (+1.59%)
RLAY | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $19.44 | ||
Change | -$0.26 (-1.32%) | ||
Open | $19.92 | ||
High | $20.17 | ||
Low | $19.18 | ||
Previous Close | $19.70 | ||
Volume | 2,965,869 | ||
30-Day Average Volume | 2,119,112 | ||
1-Week Change | -2.11% | ||
1-Month Change | 0.73% | ||
1-Year Change | 426.83% | ||
3-Year Change | 82.19% | ||
5-Year Change | -38.34% | ||
Fundamentals | |||
Shares Outstanding | 219.1M | ||
Total Assets | $967.5M | ||
Market Cap | $4.3B | ||
Enterprise Value | $4.1B | ||
Period: QTR TTM FY | |||
Revenue | $350,000.00 | ||
Net Income | -$83.7M | ||
Free Cash Flow | -$53.7M | ||
EBIT | -$83.7M | ||
EBITDA | -$83.3M | ||
Net Working Capital | $877.3M | ||
EPS | -$0.41 | ||
Enterprise Value/EBITDA | -50 | ||
Enterprise Value/Revenue | 11,826 | ||
P/B | 5 | ||
P/E | -47 | ||
PEG | N/A | ||
Price/Free Cash Flow | -79 | ||
Price/Operating Cash Flow | -79 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue